Utility Menu

Roche on midazolam

We are proud to share with you this statement from Roche regarding the use of Midazolam as an execution drug in USA.

"Project Hope to Abolish the Death Penalty
 13 January 2016

Your writings regarding Midazolam

Dear Ms. Brown, Ms. Malchau, Mr. Richard,Ms. Busch and Ms. Gabriel,dear Dr. Leitner,

Thank you for your writings regarding the use of Midazolam for capital punishment in the U. S.

We fully understand the importance of your concern. Roche is aware of the use of the Benzodiazepine Midazolam as part of a drug combination used for executions under the death penalty in the U.S.

Please let us clearly point out the fact that Roche did and does not supply Midazolam for use under the death penalty and would not knowingly provide any of our medicines for this purpose.

Roche’s focus is on developing innovative medicines and diagnostic tests that help patients live longer, better lives.Roche discovered Midazolamin the 1970s as a treatment for acute seizures, moderate to severe insomnia, and for inducing sedation and amnesia before medical procedures.

In 2004, Roche discontinued the manufacture and distribution of Midazolam in the U.S. for several reasons during a re-evaluation of our product portfolio of medicines and is now only available from generic manufacturers.

Our statement on this topic is also to be found on ourglobal website: www.roche.com/…/ac…/making_innovation_accessible/ath_who.htm.

Please do not hesitate to contact us or Dr. Mark Rogers-Evans, F. Hoffmann-La Roche Ltd, Basel, Switzerland (e-mail: mark.rogers-evans@roche.com) in case of any further concerns or questions regarding the issue.

Best regards,

Almut Jörgl
 Medical Manager Mag.

Bernadette Keusch
 Patient Relations Manager"